Table 2.
Treatment outcomes of 5-week written exposure therapy for Korean patients with PTSD
| N=25 (2 dropped out) M (SD) | Baseline (T1) | Week 6 (T2) | Week 12 (T3) | Week 24 (T4) | Effect size (partial ŋ2) |
|---|---|---|---|---|---|
| CAPS-5% free-diagnosis of PTSD | 0 of 25 (0) | 14 of 23 (60.9) | 15 of 22 (68.2) | 14 of 18 (77.8) | |
| CAPS-5 total score | 43.32 (10.03) | 24.22 (11.81)* | 20.64 (14.32)* | 19.41 (14.66)* | 0.703 |
| PCL-5 | 52.56 (13.29) | 31.04 (22.28)* | 33.00 (22.64)* | 27.83 (23.28)* | 0.524 |
| PHQ-9 | 16.92 (6.87) | 9.70 (7.92)* | 9.57 (8.51)* | 8.83 (9.14)* | 0.537 |
| GAF | 54.24 (6.33) | 63.30 (9.20)* | 65.86 (10.53)* | 71.06 (12.04)* | 0.575 |
*
p<0.001, p values refer to comparisons from baseline to T2, T3, and T4, respectively.
CAPS: Clinician Administered PTSD Scale for DSM-5, PCL-5: PTSD Check List-5, PHQ-9: Patient Health Questionnaire-9, GAF: Global Assessment of Function, PTSD: post-traumatic stress disorder, SD: standard deviation